Corrigendum: Impact of the COVID-19 pandemic on the diagnosis of tuberculosis in Brazil: Is the WHO end TB strategy at risk?

Autor: do Rosário Souza M; Health Science Graduate Program, Universidade Federal de Sergipe, São Cristóvão, Brazil.; Parasitic Biology Graduate Program, Universidade Federal de Sergipe, São Cristóvão, Brazil., Silva da Paz W; Parasitic Biology Graduate Program, Universidade Federal de Sergipe, São Cristóvão, Brazil.; Tropical Medicine Graduate Program, Universidade Federal de Pernambuco, Recife, Brazil., Dos Santos Sales VB; Department of Medicine, Universidade Federal de Sergipe, Aracaju, Brazil., Hilario de Jesus GF; Department of Medicine, Universidade Federal de Sergipe, Aracaju, Brazil., Dos Santos Tavares D; Department of Health Education, Universidade Federal de Sergipe, Lagarto, Brasil., Almeida Lima SVM; Department of Nursing, Universidade Federal de Sergipe, Lagarto, Brasil., Lopes Sousa ÁF; Global Health and Tropical Medicine (GHTM), Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal., Vieira de Melo E; Department of Medicine, Universidade Federal de Sergipe, Aracaju, Brazil., Feliciano do Carmo R; College of Pharmaceutical Sciences, Federal University of Vale do São Francisco (UNIVASF), Petrolina, Brazil., Freire de Souza CD; Department of Medicine, Universidade Federal de Alagoas, Arapiraca, Brazil., Bezerra-Santos M; Health Science Graduate Program, Universidade Federal de Sergipe, São Cristóvão, Brazil.; Parasitic Biology Graduate Program, Universidade Federal de Sergipe, São Cristóvão, Brazil.; Department of Morphology, Universidade Federal de Sergipe, São Cristóvão, Brazil.; Laboratory of Immunology and Molecular Biology, University Hospital, Universidade Federal de Sergipe, Aracaju, Brazil.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2022 Sep 06; Vol. 13, pp. 999301. Date of Electronic Publication: 2022 Sep 06 (Print Publication: 2022).